News
FDA Gives Marketing Nod to Blood Test for Diagnosing Alzheimer Disease
The first in vitro diagnostic device that uses blood samples to detect Alzheimer disease has been granted marketing clearance by the U.S. Food and Drug Administration. The Lumipulse G pTau217/ß-Amyloid 1-42 Plasma Ratio is approved for the early detection of amyloid plaques associated with Alzheimer disease in patients aged 55 years and older who are showing signs of the disease.
Hosted on MSN26d
Buckeye Tick Test Laboratory at OSU is now open for businessThe Ohio State University Buckeye Tick Test Laboratory is addressing this critical ... disease for hundreds of people and animals and the data from the tick testing will provide much needed ...
Defense News on MSN6d
Varda lands third space capsule, carrying key hypersonic flight dataVarda Space Industries, a California-based, in-orbit manufacturing company, recovered its third reentry capsule Wednesday, ...
This includes identifying the specific needs of the laboratory, such as the types of tests performed, the number of users, and the data management requirements. By defining the project goals and ...
The University of Minnesota Soil Testing Laboratory completes soil analysis for fields, lawns and gardens. A local private lab may also be an option for you. Most county Extension offices have the ...
Researchers at the University of Tokyo and their collaborators have developed a digital laboratory system that fully ...
The Food and Drug Administration is suspending a quality control program for testing of fluid milk and other dairy products ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback